Brian M. Godshaw

Brian M. Godshaw

Auto-generated profile, based on publicly available information

Brian M. Godshaw

Department of Orthopedic Surgery, Ochsner Clinic Foundation, New Orleans, LA, USA; University of Queensland, Ochsner Clinical School, New Orleans, LA, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
BGBrian M. Godshaw
Brian M. Godshaw
COConnor A. Ojard
Connor A. Ojard
TATyler M. Adams
Tyler M. Adams
GCGeorge F. Chimento
George F. Chimento
AMAlaa Mohammed
Alaa Mohammed
BWBradford S. Waddell
Bradford S. Waddell

20 August 2024 in Orthopaedic Journal of Sports Medicine
Verified
Journal Article
Open access
JHJonathan D. Hughes
Jonathan D. Hughes
SBStephanie Boden
Stephanie Boden
RBRebekah Belayneh
Rebekah Belayneh
JDJenna Dvorsky
Jenna Dvorsky
AMAsher Mirvish
Asher Mirvish
VMVolker Musahl
Volker Musahl
Background: Smaller intercondylar notch sizes have been consistently associated with a predisposition for primary anterior cruciate ligament tears. Purpose: To evaluate the association between intercondylar notch size, graft size, and postoperative complications, including knee stiffness and return to the operating room, after primary anatomic anterior cruciate ligament reconstruction (ACLR). Study Design: Case-control study; Level of evidence, 3. Methods: This was a retrospective analysis of prospectively collected data from consecutive patients who underwent anatomic single-bundle primary ACLR using a bone-patellar tendon-bone or quadriceps tendon autograft performed by fellowship-trained orthopaedic sports medicine surgeons between April 2009 and August 2019. Graft failure was defined as patient report of instability, pathologic laxity on clinical examination, or graft rerupture confirmed by magnetic resonance imaging and/or subsequent arthroscopy. To ensure the purposeful selection of covariates, univariate analyses were conducted on the list of potential confounders selected a priori, and those with a significance value of P < .10 were considered for the multivariate regression model. Covariates found to be statistically significant with univariate analysis were patient age, notch size, and graft type. After validating all potential covariates, they were added to the regression model and then eliminated in a stepwise fashion. Results: In total, 252 patients were included for analysis (99 bone-patellar tendon-bone and 153 quadriceps tendon autograft; age, 22.2 ± 7.0 years; graft size, 9.8 ± 1.0 mm; time to follow-up, 50.4 ± 28.9 months). Knee stiffness developed in 23 patients (9.1%), and 15 grafts failed (6.0%). Smaller notch size on magnetic resonance imaging was significantly associated with graft failure ( P = .005). There was a significantly higher risk of graft failure with notch size <16 versus ≥16 mm (17.6% vs 2.3%; P = .005) with an odds ratio (OR) of 5.0 (95% CI, 1.7-15.1; P = .004). Notch size <15 mm was associated with the highest risk of graft failure (22.2%; OR, 5.8; 95% CI, 1.6-20.6; P = .006). There was no significant association between notch size or graft–notch size ratio and knee stiffness, meniscal injury, or cartilage damage at the time of ACLR, regardless of graft type. Conclusion: Intercondylar notch size <16 mm was associated with a 5-fold increased risk of graft failure after primary anatomic ACLR.

27 April 2021 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Open access
PDF file
PWPhilipp W. Winkler
Philipp W. Winkler
BGBrian M. Godshaw
Brian M. Godshaw
JKJon Karlsson
Jon Karlsson
AGAlan M. J. Getgood
Alan M. J. Getgood
VMVolker Musahl
Volker Musahl

12 January 2023 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
BGBrian M. Godshaw
Brian M. Godshaw
JHJonathan D. Hughes
Jonathan D. Hughes
GLGian Andrea Lucidi
Gian Andrea Lucidi
JSJoshua Setliff
Joshua Setliff
MSMikael Sansone
Mikael Sansone
VMVolker Musahl
Volker Musahl

1 September 2020 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
BGBrian M. Godshaw
Brian M. Godshaw
MWMichael S. Warren
Michael S. Warren
MNMichael A. Nammour
Michael A. Nammour
GCGeorge F. Chimento
George F. Chimento
AMAlaa E. Mohammed
Alaa E. Mohammed
BWBradford S. Waddell
Bradford S. Waddell

23 February 2024 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Open access
BDBhumit Desai
Bhumit Desai
EAEric Assid
Eric Assid
GJGraylin Jacobs
Graylin Jacobs
ADAnouska Dasgupta
Anouska Dasgupta
BWBrian Williams
Brian Williams
Deryk Gerard JonesDeryk Gerard Jones
Deryk Gerard Jones
Purpose: Viable cartilage allograft (VCA) is a cartilage tissue matrix that contains cryopreserved viable allogeneic cartilage fibres. This study aimed to assess safety and benefits in treating focal knee cartilage defects with VCA. We hypothesized that VCA is a safe single‐stage procedure in isolated chondral defects.Method: In vitro analysis, in vivo studies and a prospective case series were performed. VCA was evaluated in a goat cartilage repair model. Symptomatic International Cartilage Repair Society grade 3/4A lesions of the femoral condyle or patella were implanted with VCA. International Knee Documentation Committee (IKDC), Knee injury and Osteoarthritis Outcome (KOOS) subscales, Lysholm, Short Form‐12, Visual Analog Scale and pain frequency levels were assessed. Radiographic and magnetic resonance imaging (MRI) was performed at regular intervals postoperatively. Data were analysed by statisticians to determine the power and significance of the results.Results: The goat study confirmed that VCA is effective for cartilage repair. Twenty patients were implanted; the mean age was 28.1 (16–56), the mean body mass index (BMI) was 27.9 ± 5.6 and the mean follow‐up was 24.1 months (range = 12.0–36.0 months). Lesions were in either the femoral condyle (7) or patella (13). Lesion sizes ranged from 1.5 to 6.0 cm2 (mean = 4.58 cm2). Outcome scores improved from preoperative baseline (POB): IKDC (78.2), Lysholm (89.0), KOOS: Pain (95.8), Symptoms (86.3), ADL (87.8), Sports (85.0) and QOL (75.0). MRI imaging demonstrated excellent osteochondral allograft assimilation. Second‐look arthroscopy (two patients) demonstrated complete fill and incorporation (Brittberg scores 11/12). Functional scores were maintained at 24 (M): IKDC (86.24 ± 17.2), Lysholm (87.23 ± 15.0), KOOS: Pain (91.72 ± 17.3), Symptoms (84.92 ± 16.1), ADLs (93.80 ± 16.1), Sports (84.45 ± 27.7), QOL (81.30 ± 20.8).Conclusion: VCA is an off‐the‐shelf, single‐stage, conformable allogeneic graft that treats chondral defects with no additional fixation. Preclinical and short‐term prospective clinical studies show that VCA can safely treat chondral defects with potential advantages to existing options.Level of Evidence: Level IV study.